Fidelity Nasdaq Composite Index ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.21
資產淨值: 89.45
成立日期: 25/09/2003
 
分析
市值分佈:
96.62%
大市值
2.35%
中市值
0.31%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:53) 總持有投資項目: 987  
0%
 
100%
     10大 (58.19%)
代號 名稱 佔比% 持有日期
GLUEMonte Rosa Therapeutics0.00427/02/2026
RCATRed Cat Holdings0.00427/02/2026
DSGNDesign Therapeutics0.00427/02/2026
CAPRCapricor Therapeutics0.00427/02/2026
SPRYARS Pharmaceuticals0.00427/02/2026
JBIOJade Biosciences Inc0.00427/02/2026
SOCASolarius Capital Acquisition Corp.0.00427/02/2026
BCAXBicara Therapeutics Inc.0.00427/02/2026
CMPXCompass Therapeutics0.00427/02/2026
TSHATaysha Gene Therapies0.00427/02/2026
TIGRUP Fintech Holding Ltd0.00427/02/2026
EVLVEvolv Technologies Holdings0.00427/02/2026
CCOICogent Communications Holdings0.00427/02/2026
FTREFortrea Holdings0.00427/02/2026
MBAVM3 Brigade Acquisition V Corp.0.00427/02/2026
SANASana Biotechnology0.00427/02/2026
INBXInhibrx Biosciences Inc.0.00427/02/2026
IPCXInflection Point Acquisition Corp III0.00427/02/2026
ALVOAlvotech0.00427/02/2026
ATAIAtaiBeckley Inc0.00427/02/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20    21    22    23    24    25    26    27    28    29    30    31    32    33    34    35    36    37    38    39    40    41    42    43    44    45   46    47    48    49    50  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.